[
    {
        "question_id": "9480_B_7",
        "new_question_id": "48953",
        "question_type": "0",
        "category": "4",
        "concept_id_link": "1524",
        "notes_id_link": "1_175",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Intravenous metronidazole",
            "Intravenous vancomycin",
            "Oral fidaxomicin",
            "Oral metronidazole",
            "Oral vancomycin",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 53-year-old man presents to the emergency department with a 5-day history of diarrhoea. He has no past medical history, but two weeks ago, he had a chest infection and received a 10-day course of co-amoxiclav from his general practitioner. He has no known drug allergies. <br /><br />His blood pressure is 122/82 mmHg, heart rate is 92/min, and temperature is 37.1\u00baC.<br /><br />A stool culture is positive for <i>Clostridioides difficile</i> toxin.<br /><br />What is the most appropriate treatment?",
            "",
            ""
        ],
        "answers": [
            "5",
            "0",
            "0"
        ],
        "notes": [
            "<b>Oral vancomycin</b> is the first line treatment option for <i>C. difficile</i>. A 10-day course is recommended. Intravenous metronidazole would be added if there was a life-threatening infection, but there is no suggestion of this here.<br /><br /><b>Intravenous metronidazole</b> is combined with oral vancomycin as a third-line treatment or in life-threatening disease. This patient's observations are stable, with no evidence of severe or life-threatening disease. Therefore, he should be started on the first-line treatment, oral vancomycin.<br /><br /><b>Intravenous vancomycin</b> is not used in the treatment of <i>C. difficile</i>. This is because it will not be excreted into the gastrointestinal and would not provide effective treatment. On the other hand, oral vancomycin will accumulate in the gastrointestinal system, and so is the first-line treatment option.<br /><br /><b>Oral fidaxomicin</b> is a second line therapy for <i>C difficile</i> infection. It may also be used for recurrent <i>C. difficile</i> cases. In this case, there is no suggestion this is a recurrence of the disease, so first-line treatment remains oral vancomycin.<br /><br /><b>Oral metronidazole</b> is not used in the treatment of <i>C difficile</i>. Intravenous metronidazole may be added to oral vancomycin as a third-line treatment option or for life-threatening infections. Nothing in the question suggests a life-threatening infection, so the first-line treatment would be oral vancomycin.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 53-year-old man presents to the emergency department with a 5-day history of diarrhoea. He has no past medical history, but two weeks ago, he had a chest infection and received a 10-day course of co-amoxiclav from his general practitioner. He has no known drug allergies. <br /><br />His blood pressure is 122/82 mmHg, heart rate is 92/min, and temperature is 37.1\u00baC.<br /><br />A stool culture is positive for <i>Clostridioides difficile</i> toxin.<br /><br />What is the most appropriate treatment?",
        "correct_answer": "5",
        "question_notes": "<b>Oral vancomycin</b> is the first line treatment option for <i>C. difficile</i>. A 10-day course is recommended. Intravenous metronidazole would be added if there was a life-threatening infection, but there is no suggestion of this here.<br /><br /><b>Intravenous metronidazole</b> is combined with oral vancomycin as a third-line treatment or in life-threatening disease. This patient's observations are stable, with no evidence of severe or life-threatening disease. Therefore, he should be started on the first-line treatment, oral vancomycin.<br /><br /><b>Intravenous vancomycin</b> is not used in the treatment of <i>C. difficile</i>. This is because it will not be excreted into the gastrointestinal and would not provide effective treatment. On the other hand, oral vancomycin will accumulate in the gastrointestinal system, and so is the first-line treatment option.<br /><br /><b>Oral fidaxomicin</b> is a second line therapy for <i>C difficile</i> infection. It may also be used for recurrent <i>C. difficile</i> cases. In this case, there is no suggestion this is a recurrence of the disease, so first-line treatment remains oral vancomycin.<br /><br /><b>Oral metronidazole</b> is not used in the treatment of <i>C difficile</i>. Intravenous metronidazole may be added to oral vancomycin as a third-line treatment option or for life-threatening infections. Nothing in the question suggests a life-threatening infection, so the first-line treatment would be oral vancomycin.",
        "answer_order": "5",
        "answer": "5",
        "title": "<i>Clostridioides difficile</i>",
        "body": "<i>Clostridioides difficile</i> is a <span class=\"concept\" data-cid=\"1867\">Gram positive rod</span> often encountered in hospital practice. It produces an exotoxin which causes intestinal damage leading to a syndrome called pseudomembranous colitis. <i>C. difficile</i> develops when the normal gut flora are suppressed by broad-spectrum antibiotics. <span class=\"concept\" data-cid=\"987\">Clindamycin</span> is historically associated with causing <i>C. difficile</i> but the aetiology has evolved significantly over the past 10 years. Second and third-generation <span class=\"concept\" data-cid=\"431\">cephalosporins</span> are now the leading cause of <i>C. difficile</i>.<br /><br />Other than antibiotics, risk factors include:<br /><ul><li><span class=\"concept\" data-cid=\"1773\">proton pump inhibitors</span></li></ul><br />Pathophysiology<br /><ul><li>anaerobic gram-positive, spore-forming, toxin-producing bacillus </li><li>transmission: via the <span class=\"concept\" data-cid=\"12028\">faecal-oral route by ingestion of spores</span></li><li>releases two exotoxins (toxin A and toxin B) that act on intestinal epithelial cells and inflammatory cells resulting in colitis</li></ul><br />Features<br /><ul><li>diarrhoea</li><li>abdominal pain</li><li>a <b>raised white blood cell count (WCC)</b> is characteristic</li><li>if severe toxic megacolon may develop</li></ul><br />The Public Health England severity scale is often used as this may determine treatment:<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th>Mild</th><th>Moderate</th><th>Severe</th><th>Life-threatening</th></tr></thead><tbody><tr><td><span class=\"concept\" data-cid=\"11061\">Normal WCC</span></td><td><span class=\"concept\" data-cid=\"11061\">\u2191 WCC ( < 15 x 10<sup>9</sup>/L)</span><br />Typically 3-5 loose stools per day</td><td><span class=\"concept\" data-cid=\"11061\">\u2191 WCC ( > 15 x 10<sup>9</sup>/L)</span><br />  or an acutely \u2191 creatinine (> 50% above baseline)<br />  or a temperature > 38.5\u00b0C<br /> or evidence of severe colitis(abdominal or radiological signs)</td><td>Hypotension<br />Partial or complete ileus<br />Toxic megacolon, or CT evidence of severe disease</td></tr></tbody></table></div><br />Diagnosis<br /><ul><li>is made by detecting <i>C. difficile</i> <b>toxin</b> (CDT) in the stool</li><li><i>C. difficile</i> <span class=\"concept\" data-cid=\"9585\"><b>antigen</b> positivity only shows exposure to the bacteria, rather than current infection</span></li></ul><br /><h5 class='notes-heading'>Management</h5><br />Current antibiotic therapy should be reviewed and antibiotics stopped if possible.<br /><br />First episode of <i>C. difficile</i> infection<br /><ul><li><b>first-line therapy is <span class=\"concept\" data-cid=\"1524\">oral vancomycin</span></b> for 10 days</li><li>second-line therapy: <span class=\"concept\" data-cid=\"4516\">oral fidaxomicin</span> </li><li>third-line therapy: <span class=\"concept\" data-cid=\"11463\">oral vancomycin +/- IV metronidazole</span></li></ul><br />Recurrent episode <br /><ul><li>recurrent infection occurs in around 20% of patients, increasing to 50% after their second episode</li><li><span class=\"concept\" data-cid=\"11464\">within 12 weeks of symptom resolution: oral fidaxomicin</span></li><li>after 12 weeks of symptom resolution: oral vancomycin OR fidaxomicin</li></ul><br />Life-threatening <i>C. difficile</i> infection<br /><ul><li><span class=\"concept\" data-cid=\"1489\">oral vancomycin AND IV metronidazole</span></li><li>specialist advice - surgery may be considered</li></ul><br />Other therapies<br /><ul><li><span class=\"concept\" data-cid=\"2406\">bezlotoxumab</span> is a monoclonal antibody which targets <i>C. difficile</i> toxin B<ul><li>NICE do not currently support its use to prevent recurrences as it is not cost-effective</li></ul></li><li>faecal microbiota transplant<ul><li>may be considered for patients who've had 2 or more previous episodes</li></ul></li></ul><br /><span class=\"concept\" data-cid=\"12138\">Preventing the spread of <i>C. difficile</i> infection</span><br /><ul><li><span class=\"concept\" data-cid=\"3075\">isolation in side room</span>: the patient should remain isolated until there has been no diarrhoea (types 5-7</li></ul>on the Bristol Stool Chart) for at least 48 hours<br /><ul><li>all staff should wear disposable gloves and an apron during any contact with patients known to have <i>C. difficile</i></li><li>hand washing is also essential - alcohol gel does not kill the spores of <i>C. difficile</i></li></ul><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/xrb133b.jpg\" data-fancybox=\"gallery\" data-caption=\"Elderly lady with infectious colitis secondary to <i>C. difficile</i>. On the abdominal film note the loss of bowel wall architecture and thumb-printing consistent with colitis. The CT from the same patient is enhanced by oral contrast. There is moderate free fluid in pelvis and peritoneum. The colon is oedematous throughout with enhancing walls, but of normal calibre. The sigmoid colon is smooth and featureless. Small bowel, liver, spleen, kidneys, adrenals and pancreas are normal.\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/xrb133.jpg\" alt=\"\" /></a></div></div></div>",
        "notes_hash": "d9d1ce2c481a73d49cfddd688e80c01b",
        "knowledge_graph_node_id_link": 1152,
        "concept": "Oral vancomycin is the first line antibiotic for use in patients with <i>C. difficile</i> infection",
        "concept_percentile": "51",
        "concept_colour": "rgb(249,255,0)",
        "number_attempts": "5855",
        "up_votes": "13",
        "down_votes": "5",
        "column_array": [
            0,
            "56",
            "296",
            "166",
            "339",
            "4998",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_87\" data-linkid=\"87\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_87\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">20</span><button type=\"button\" style=\"\" id=\"link_dislike_87\" data-linkid=\"87\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_87\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">23</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/advice/esmpb1/chapter/key-points-from-the-evidence\">Clostridium difficile infection: risk with broad-spectrum antibiotics</a></td></tr></table><br><br><table style='width:100%'><tr><td>Canadian Medical Journal</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_854\" data-linkid=\"854\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_854\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">14</span><button type=\"button\" style=\"\" id=\"link_dislike_854\" data-linkid=\"854\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_854\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">13</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"http://www.cmaj.ca/content/179/8/767/F3.large.jpg\">Relative risk of developing Clostridium difficile</a></td></tr></table><br><br><table style='width:100%'><tr><td>Medcomic</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_2062\" data-linkid=\"2062\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_2062\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">33</span><button type=\"button\" style=\"\" id=\"link_dislike_2062\" data-linkid=\"2062\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_2062\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">13</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.medcomic.com/medcomic/clostridium-difficile-infection\">Clostridium difficile Infection</a></td></tr></table><br><br><table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_2048\" data-linkid=\"2048\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_2048\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">40</span><button type=\"button\" style=\"\" id=\"link_dislike_2048\" data-linkid=\"2048\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_2048\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">11</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng199/chapter/Recommendations\">2021 Clostridioides difficile infection guidelines</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Bpe94DaI6Pc\" data-description=\"Understanding Clostridium Difficile Infection\" data-upvotes=\"2\" data-downvotes=\"0\" data-media=\"1501\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/Bpe94DaI6Pc/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Bpe94DaI6Pc\" data-description=\"Understanding Clostridium Difficile Infection\" data-upvotes=\"2\" data-downvotes=\"0\" data-media=\"1501\">Understanding Clostridium Difficile Infection</a></td></tr><tr><td><span ><small>Zero To Finals - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2644\" data-mediaid=\"2644\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2644\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"media_dislike_2644\" data-mediaid=\"2644\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2644\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr></table>",
        "comment_count": 2,
        "concepts_for_notes": {
            "987": {
                "concept_text": "Clindamycin treatment is associated with a high risk of <i>C. difficile</i>",
                "concept_percentile": "72"
            },
            "1489": {
                "concept_text": "In life-threatening <i>C. difficile</i> infection treatment is with ORAL vancomycin and IV metronidazole",
                "concept_percentile": "95"
            },
            "1524": {
                "concept_text": "Oral vancomycin is the first line antibiotic for use in patients with <i>C. difficile</i> infection",
                "concept_percentile": "51"
            },
            "1773": {
                "concept_text": "PPIs are a risk factor for <i>C. difficile</i> infection ",
                "concept_percentile": "69"
            },
            "4516": {
                "concept_text": "If <i> C. difficile </i> does not respond to first-line vancomycin , oral fidaxomicin should be used next, except in life-threatening infections",
                "concept_percentile": "57"
            },
            "11463": {
                "concept_text": "If a first episode of <i>C. difficile </i> doesn't respond to either vancomycin or fidaxomicin then oral vancomycin +/- IV metronidazole should be tried",
                "concept_percentile": "73"
            },
            "11464": {
                "concept_text": "A recurrent episode of <i>C. difficile</i> within 12 weeks of symptom resolution should be treated with oral fidaxomicin",
                "concept_percentile": "67"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_1760",
        "new_question_id": "2219",
        "question_type": "0",
        "category": "7",
        "concept_id_link": "0",
        "notes_id_link": "1_1295",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Normal development",
            "Global developmental delay",
            "Isolated delay in gross motor skills",
            "Delay in speech + social skills, possibly early autism",
            "Isolated delay in fine motor skills",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "You are reviewing a 11-month-old baby with a viral upper respiratory tract infection. She is clinically well but at the end of the consultation her mother asks you about her development. You notice that she points and babbles 'mama' and 'dada' but has no other words. She is shy and cries when you try to examine her.  There is an early pincer grip and she can roll from front to back but she cannot yet sit without support. How would you describe her development?",
            "",
            ""
        ],
        "answers": [
            "3",
            "",
            ""
        ],
        "notes": [
            "Most babies can sit without support at 7-8 months so this probably represents a delay in gross motor skills. If still present at 12 months she should be considered for referral to a paediatrician. The other development features are normal for her age.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "You are reviewing a 11-month-old baby with a viral upper respiratory tract infection. She is clinically well but at the end of the consultation her mother asks you about her development. You notice that she points and babbles 'mama' and 'dada' but has no other words. She is shy and cries when you try to examine her.  There is an early pincer grip and she can roll from front to back but she cannot yet sit without support. How would you describe her development?",
        "correct_answer": "3",
        "question_notes": "Most babies can sit without support at 7-8 months so this probably represents a delay in gross motor skills. If still present at 12 months she should be considered for referral to a paediatrician. The other development features are normal for her age.",
        "answer_order": "3",
        "answer": "3",
        "title": "Developmental milestones: gross motor",
        "body": "The table below summarises the major gross motor developmental milestones<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th><b>Age</b></th><th><b>Milestone</b></th></tr></thead><tbody><tr><td>3 months</td><td>Little or no head lag on being pulled to sit<br />Lying on abdomen, good head control<br />Held sitting, lumbar curve</td></tr><tr><td>6 months</td><td>Lying on abdomen, arms extended<br />Lying on back, lifts and grasps feet<br />Pulls self to sitting<br />Held sitting, back straight<br /><span class=\"concept\" data-cid=\"8655\">Rolls front to back</span></td></tr><tr><td>7-8 months</td><td><span class=\"concept\" data-cid=\"8654\">Sits without support</span> (Refer at 12 months)</td></tr><tr><td>9 months</td><td><span class=\"concept\" data-cid=\"8652\">Pulls to standing</span><br /><span class=\"concept\" data-cid=\"8653\">Crawls</span></td></tr><tr><td>12 months</td><td>Cruises<br />Walks with one hand held</td></tr><tr><td>13-15 months</td><td><span class=\"concept\" data-cid=\"8651\">Walks unsupported</span> (Refer at 18 months)</td></tr><tr><td>18 months</td><td>Squats to pick up a toy</td></tr><tr><td>2 years</td><td>Runs<br />Walks upstairs and downstairs holding on to rail</td></tr><tr><td>3 years</td><td><span class=\"concept\" data-cid=\"8649\">Rides a tricycle using pedals</span><br />Walks up stairs without holding on to rail</td></tr><tr><td>4 years</td><td><span class=\"concept\" data-cid=\"8650\">Hops on one leg</span></td></tr></tbody></table></div><br />Notes<br /><ul><li>the majority of children crawl on all fours before walking but some children 'bottom-shuffle'. This is a normal variant and <span class=\"concept\" data-cid=\"8648\">runs</span> in families</li></ul>",
        "notes_hash": "13abe20d5b4e3696476a549156e36837",
        "knowledge_graph_node_id_link": 0,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "7033",
        "up_votes": "54",
        "down_votes": "57",
        "column_array": [
            0,
            "1935",
            "883",
            "3928",
            "182",
            "105",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>MRCPCH Clinical revision</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_340\" data-linkid=\"340\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_340\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">33</span><button type=\"button\" style=\"\" id=\"link_dislike_340\" data-linkid=\"340\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_340\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">9</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://mrcpch.paediatrics.co.uk/wp-content/uploads/2014/06/Development-Assessment-MRCPCH-Website.pdf\">Summary of developmental schedule</a></td></tr></table>",
        "media": "",
        "comment_count": 4,
        "concepts_for_notes": {
            "8651": {
                "concept_text": "Walks unsupported - 13-15 months",
                "concept_percentile": "25"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_E_83",
        "new_question_id": "2081",
        "question_type": "1",
        "category": "11",
        "concept_id_link": "0",
        "notes_id_link": "1_1254",
        "theme": "Miscarriage",
        "instruction": "For each one of the following scenarios select the most appropriate diagnosis:",
        "options": [
            "",
            "Missed miscarriage",
            "Inevitable miscarriage",
            "Threatened miscarriage",
            "Complete miscarriage",
            "Recurrent miscarriage",
            "Normal pregnancy",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 6,
        "questions": [
            "A woman who is 9 weeks pregnant presents with vaginal bleeding. The cervical os is closed. An ultrasound shows an intrauterine pregnancy with a fetal heart. She has been pregnant once before which resulted in a miscarriage",
            "R 22-pvri-fcu nfdre yrj r sffbzex lckirjfleu jtre. Yvi crjk dvejkilrc gvizfu nrj 8 nvvbj rxf. Kyzj jyfnj re zekirlkvizev jrt nzky ef wvkrc gfcv. Kyvjv wzeuzexj riv tfewzidvu nzky r kirejmrxzerc lckirjfleu.",
            "R nfdre nyf zj 10 nvvbj givxerek givjvekj nzky yvrmp mrxzerc scvvuzex reu tirdgp cfnvi rsufdzerc grzej. Fe vordzerkzfe jfdv tcfkj riv jvve rifleu re fgve tvimztrc fj"
        ],
        "answers": [
            "3",
            "1",
            "2"
        ],
        "notes": [
            "The possibility of bleeding due to non-pregnancy causes (e.g. cervical ectropion) should also be considered",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A woman who is 9 weeks pregnant presents with vaginal bleeding. The cervical os is closed. An ultrasound shows an intrauterine pregnancy with a fetal heart. She has been pregnant once before which resulted in a miscarriage",
        "correct_answer": "3",
        "question_notes": "The possibility of bleeding due to non-pregnancy causes (e.g. cervical ectropion) should also be considered",
        "answer_order": "3",
        "answer": "3",
        "title": "Miscarriage",
        "body": "Threatened miscarriage<br /><ul><li>painless vaginal bleeding occurring before 24 weeks, but typically occurs at 6 - 9 weeks</li><li>the bleeding is often less than menstruation</li><li>cervical os is closed</li><li>complicates up to 25% of all pregnancies</li></ul><br />Missed (delayed) miscarriage<br /><ul><li>a gestational sac which contains a dead fetus before 20 weeks without the symptoms of expulsion</li><li>mother may have light vaginal bleeding / discharge and the symptoms of pregnancy which disappear. Pain is not usually a feature</li><li>cervical os is closed</li><li>when the gestational sac is > 25 mm and no embryonic/fetal part can be seen it is sometimes described as a 'blighted ovum' or 'anembryonic pregnancy'</li></ul><br />Inevitable miscarriage<br /><ul><li>heavy bleeding with clots and pain</li><li>cervical os is open</li></ul><br />Incomplete miscarriage<br /><ul><li>not all products of conception have been expelled</li><li>pain and vaginal bleeding</li><li> cervical os is open</li></ul>",
        "notes_hash": "1d3234315c84284604a5c53f47b9f046",
        "knowledge_graph_node_id_link": 1168,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "6574",
        "up_votes": "30",
        "down_votes": "36",
        "column_array": [
            0,
            "5426",
            "4516",
            "4933",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1688\" data-linkid=\"1688\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1688\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">8</span><button type=\"button\" style=\"\" id=\"link_dislike_1688\" data-linkid=\"1688\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1688\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">4</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng126/chapter/Recommendations\">2023 Ectopic pregnancy and miscarriage: diagnosis and initial management</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/7TmtJPpeiSo\" data-description=\"Miscarriage Basics and Types\" data-upvotes=\"12\" data-downvotes=\"1\" data-media=\"1014\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/7TmtJPpeiSo/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/7TmtJPpeiSo\" data-description=\"Miscarriage Basics and Types\" data-upvotes=\"12\" data-downvotes=\"1\" data-media=\"1014\">Miscarriage Basics and Types</a></td></tr><tr><td><span ><small>Individual - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1789\" data-mediaid=\"1789\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1789\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">12</span><button type=\"button\" style=\"\" id=\"media_dislike_1789\" data-mediaid=\"1789\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1789\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr></table>",
        "comment_count": 8,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    },
    {
        "question_id": "17798_B_11",
        "new_question_id": "29278",
        "question_type": "0",
        "category": "1",
        "concept_id_link": "1329",
        "notes_id_link": "1_1176",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Adenosine",
            "Amiodarone",
            "Atropine infusion",
            "Direct current cardioversion",
            "External pacing",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 78-year-old patient has been undergoing treatment for symptomatic bradycardia.<br /><br />After several boluses of atropine, the patient remains unwell with a blood pressure of 84/53mmHg, heart rate of 34 beats per minute, respiratory rate of 23 breaths per minute, oxygen saturation of 97%, and a temperature of 37.2\u00baC.  The patient is confused and sweating, with cold and clammy extremities.<br /><br />What is the <b>most appropriate</b> next step in the management of this patient?",
            "",
            ""
        ],
        "answers": [
            "5",
            "0",
            "0"
        ],
        "notes": [
            "<b>External (transcutaneous) pacing</b> is the next step in management of symptomatic bradycardia. It is a temporary measure that delivers pacing of the heart through the chest wall until more permanent pacing may be established.<br /><br />Adenosine, used in the management of tachyarrhythmias (such as supraventricular tachycardias), is widely reported to make patients feel terrible, including a sense of 'impending doom,' although it has a very short half-life, so these side effects do not last long. It is not the next treatment option in this situation. <br /><br />Amiodarone is used in the management of tachyarrhythmias (such as ventricular tachycardia), as well as in cardiopulmonary resuscitation, for ventricular fibrillation or pulseless ventricular tachycardia (which do not respond to initial chest compressions or defibrillation). It would not be an appropriate treatment option for this patient for bradycardia. <br /><br />Atropine is not routinely given as an infusion, however, atropine as an intravenous bolus is used in many circumstances such as symptomatic bradycardia (in this example), or in combination with other medications in organophosphorus insecticide poisoning.<br /><br />Direct-current cardioversion is not routinely used in the management of symptomatic bradycardia. If the patient deteriorated to a point of cardiac arrest with a rhythm of ventricular tachycardia or ventricular fibrillation, defibrillation would be required.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 78-year-old patient has been undergoing treatment for symptomatic bradycardia.<br /><br />After several boluses of atropine, the patient remains unwell with a blood pressure of 84/53mmHg, heart rate of 34 beats per minute, respiratory rate of 23 breaths per minute, oxygen saturation of 97%, and a temperature of 37.2\u00baC.  The patient is confused and sweating, with cold and clammy extremities.<br /><br />What is the <b>most appropriate</b> next step in the management of this patient?",
        "correct_answer": "5",
        "question_notes": "<b>External (transcutaneous) pacing</b> is the next step in management of symptomatic bradycardia. It is a temporary measure that delivers pacing of the heart through the chest wall until more permanent pacing may be established.<br /><br />Adenosine, used in the management of tachyarrhythmias (such as supraventricular tachycardias), is widely reported to make patients feel terrible, including a sense of 'impending doom,' although it has a very short half-life, so these side effects do not last long. It is not the next treatment option in this situation. <br /><br />Amiodarone is used in the management of tachyarrhythmias (such as ventricular tachycardia), as well as in cardiopulmonary resuscitation, for ventricular fibrillation or pulseless ventricular tachycardia (which do not respond to initial chest compressions or defibrillation). It would not be an appropriate treatment option for this patient for bradycardia. <br /><br />Atropine is not routinely given as an infusion, however, atropine as an intravenous bolus is used in many circumstances such as symptomatic bradycardia (in this example), or in combination with other medications in organophosphorus insecticide poisoning.<br /><br />Direct-current cardioversion is not routinely used in the management of symptomatic bradycardia. If the patient deteriorated to a point of cardiac arrest with a rhythm of ventricular tachycardia or ventricular fibrillation, defibrillation would be required.",
        "answer_order": "5",
        "answer": "5",
        "title": "Peri-arrest rhythms: bradycardia",
        "body": "The 2021 Resuscitation Council (UK) guidelines emphasise that the management of bradycardia depends on:<br /><ul><li>1. identifying the presence of signs indicating haemodynamic compromise - 'adverse signs'</li><li>2. identifying the potential risk of asystole</li></ul><br /><h5 class='notes-heading'>Adverse signs</h5><br />The following factors indicate haemodynamic compromise and hence the need for treatment:<br /><ul><li>shock: hypotension (systolic blood pressure < 90 mmHg), pallor, sweating, cold, clammy extremities, confusion or impaired consciousness</li><li>syncope</li><li>myocardial ischaemia</li><li>heart failure </li></ul><br /><span class=\"concept\" data-cid=\"1328\">Atropine (500mcg IV)</span> is the first line treatment in this situation.<br /><br />If there is an unsatisfactory response the following interventions may be used:<br /><ul><li><span class=\"concept\" data-cid=\"5237\">atropine, up to a maximum of 3mg</span></li><li><span class=\"concept\" data-cid=\"1329\">transcutaneous pacing</span></li><li><span class=\"concept\" data-cid=\"11310\">isoprenaline/adrenaline infusion</span> titrated to response</li></ul><br />Specialist help should be sought for consideration of <span class=\"concept\" data-cid=\"11309\">transvenous pacing</span> if there is no response to the above measures.<br /><br /><div class=\"container\"><div class=\"row\"><div class=\"col-md-3\"><a href=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd966b.png\" data-fancybox=\"gallery\" data-caption=\"\"><img  class=\"img-thumbnail mx-auto d-block\" style=\"max-height:150px;margin-bottom:10px;\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/pdd966.png\" alt=\"\" /></a></div></div></div><br /><h5 class='notes-heading'>Potential risk of asystole</h5><br />The following are <span class=\"concept\" data-cid=\"11311\">risk factors for asystole</span>. Even if there is a satisfactory response to atropine specialist help is indicated to consider the need for transvenous pacing:<br /><ul><li>complete heart block with broad complex QRS</li><li>recent asystole</li><li>Mobitz type II AV block</li><li>ventricular pause > 3 seconds</li></ul>",
        "notes_hash": "39df0e772d90eaa5dfaecde477fd4340",
        "knowledge_graph_node_id_link": 0,
        "concept": "External pacing is used for symptomatic bradycardia if atropine fails",
        "concept_percentile": "84",
        "concept_colour": "rgb(81,255,0)",
        "number_attempts": "6103",
        "up_votes": "24",
        "down_votes": "12",
        "column_array": [
            0,
            "81",
            "75",
            "488",
            "1359",
            "4100",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Resuscitation Council UK</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_2054\" data-linkid=\"2054\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_2054\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">20</span><button type=\"button\" style=\"\" id=\"link_dislike_2054\" data-linkid=\"2054\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_2054\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">11</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.resus.org.uk/sites/default/files/2021-04/Bradycardia%20Algorithm%202021.pdf\">2021 Bradycardia algorithm</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/RuxKTCv_s0M\" data-description=\"Arrhythmia Overview - Mechanism of bradyarrhythmia and tachyarrhythmia\" data-upvotes=\"7\" data-downvotes=\"1\" data-media=\"1089\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/RuxKTCv_s0M/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/RuxKTCv_s0M\" data-description=\"Arrhythmia Overview - Mechanism of bradyarrhythmia and tachyarrhythmia\" data-upvotes=\"7\" data-downvotes=\"1\" data-media=\"1089\">Arrhythmia Overview - Mechanism of bradyarrhythmia and tachyarrhythmia</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1889\" data-mediaid=\"1889\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1889\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">7</span><button type=\"button\" style=\"\" id=\"media_dislike_1889\" data-mediaid=\"1889\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1889\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr></table>",
        "comment_count": 5,
        "concepts_for_notes": {
            "1329": {
                "concept_text": "External pacing is used for symptomatic bradycardia if atropine fails",
                "concept_percentile": "84"
            },
            "5237": {
                "concept_text": "Patients with bradycardia and signs of shock require 500micrograms of atropine (repeated up to max 3mg)",
                "concept_percentile": "80"
            },
            "11309": {
                "concept_text": "Transvenous pacing should be considered if a bradycardia doesn't respond to drugs or transcutaneous pacing",
                "concept_percentile": "71"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "19228_B_21",
        "new_question_id": "33709",
        "question_type": "0",
        "category": "3",
        "concept_id_link": "150",
        "notes_id_link": "1_1035",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Hyperkalaemic metabolic acidosis",
            "Hyperkalaemic respiratory alkalosis",
            "Hypokalaemic metabolic acidosis",
            "Hypokalaemic metabolic alkalosis",
            "Hypokalaemic respiratory acidosis",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 38-year-old woman presents with a litany of symptoms that have been ongoing for the past four months. These include weight gain, which particularly bothers her around the abdomen, with troubling purplish stretch marks, thin skin and easy bruising. She has been noticing increased swelling in her ankles and poor mood. In the diagnostic work-up, a range of laboratory tests is taken.<br /><br />What is the expected electrolyte abnormality in this patient?",
            "",
            ""
        ],
        "answers": [
            "4",
            "0",
            "0"
        ],
        "notes": [
            "This patient has Cushing's syndrome, a disease characterised by cortisol excess. Most commonly, it is related to exogenous glucocorticoid therapy but may also stem from autonomous overproduction by the adrenal glands or increased production of adrenocorticotrophic hormone. Cortisol at high levels can simulate the effects of aldosterone. There is increased sodium and subsequently water retention and increased potassium excretion, resulting in hypokalaemia. Bicarbonate resorption is increased in the tubules with potassium depletion causing metabolic alkalosis. Due to the potassium excretion, there is a <b>hypokalaemic metabolic alkalosis </b><br /><br /><b>Hyperkalaemic metabolic acidosis</b> would not be expected, as the effect of cortisol on the mineralocorticoid receptor causes a loss of potassium.<br /><br /><b>Hyperkalaemic respiratory alkalosis</b> is also not expected, as the effect of cortisol on the mineralocorticoid receptor leads to potassium excretion. Additionally, any acid-base disturbance in Cushing's syndrome is likely to be metabolically mediated rather than respiratory.<br /><br /><b>Hypokalaemic metabolic acidosis</b> is not expected as the concomitant loss of potassium and reabsorption of bicarbonate causes metabolic alkalosis. <br /><br /><b>Hypokalaemic respiratory acidosis</b> would not be expected as the acid-base disturbance is related to the reabsorption of bicarbonate. Additionally, any acid-base disturbance in Cushing's syndrome is likely to be metabolically mediated rather than respiratory.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 38-year-old woman presents with a litany of symptoms that have been ongoing for the past four months. These include weight gain, which particularly bothers her around the abdomen, with troubling purplish stretch marks, thin skin and easy bruising. She has been noticing increased swelling in her ankles and poor mood. In the diagnostic work-up, a range of laboratory tests is taken.<br /><br />What is the expected electrolyte abnormality in this patient?",
        "correct_answer": "4",
        "question_notes": "This patient has Cushing's syndrome, a disease characterised by cortisol excess. Most commonly, it is related to exogenous glucocorticoid therapy but may also stem from autonomous overproduction by the adrenal glands or increased production of adrenocorticotrophic hormone. Cortisol at high levels can simulate the effects of aldosterone. There is increased sodium and subsequently water retention and increased potassium excretion, resulting in hypokalaemia. Bicarbonate resorption is increased in the tubules with potassium depletion causing metabolic alkalosis. Due to the potassium excretion, there is a <b>hypokalaemic metabolic alkalosis </b><br /><br /><b>Hyperkalaemic metabolic acidosis</b> would not be expected, as the effect of cortisol on the mineralocorticoid receptor causes a loss of potassium.<br /><br /><b>Hyperkalaemic respiratory alkalosis</b> is also not expected, as the effect of cortisol on the mineralocorticoid receptor leads to potassium excretion. Additionally, any acid-base disturbance in Cushing's syndrome is likely to be metabolically mediated rather than respiratory.<br /><br /><b>Hypokalaemic metabolic acidosis</b> is not expected as the concomitant loss of potassium and reabsorption of bicarbonate causes metabolic alkalosis. <br /><br /><b>Hypokalaemic respiratory acidosis</b> would not be expected as the acid-base disturbance is related to the reabsorption of bicarbonate. Additionally, any acid-base disturbance in Cushing's syndrome is likely to be metabolically mediated rather than respiratory.",
        "answer_order": "4",
        "answer": "4",
        "title": "Cushing's syndrome: investigations",
        "body": "This section will consider:<br /><ul><li>the general lab findings consistent with Cushing's syndrome</li><li>tests to confirm whether a patient indeed has Cushing's syndrome</li><li>tests to find the underlying cause of Cushing's syndrome</li></ul><br />It is useful to bear in mind the possible causes:<br /><ul><li>iatrogenic: corticosteroid therapy</li><li>ACTH-dependent causes<ul><li>Cushing's disease (a pituitary adenoma \u2192 ACTH secretion) </li><li>ectopic ACTH secretion secondary to a malignancy</li></ul></li><li>ACTH-independent causes<ul><li>adrenal adenoma</li></ul></li></ul><br /><h5 class='notes-heading'>General findings consistent with Cushing's syndrome</h5><br />A <span class=\"concept\" data-cid=\"150\">hypokalaemic metabolic alkalosis</span> may be seen, along with impaired glucose tolerance.<br /><br />Ectopic ACTH secretion (e.g. secondary to small cell lung cancer) is characteristically associated with very low potassium levels. <br /><br /><h5 class='notes-heading'>Tests to confirm Cushing's syndrome</h5><br />The three most commonly used tests are:<br /><ul><li><span class=\"concept\" data-cid=\"151\">overnight (low-dose) dexamethasone suppression test</span><ul><li>this is the most sensitive test and is now used first-line to test for Cushing's syndrome</li><li>patients with Cushing's syndrome do not have their morning cortisol spike suppressed</li></ul></li><li>24 hr urinary free cortisol<ul><li>two measurements are required</li></ul></li><li>bedtime salivary cortisol<ul><li>two measurements are required</li></ul></li></ul><br /><h5 class='notes-heading'>Localisation tests</h5><br />The first-line localisation is 9am and midnight plasma ACTH (and cortisol) levels. If ACTH is suppressed then a non-ACTH dependent cause is likely such as an adrenal adenoma<br /><br /><h6 class='notes-subheading'>High-dose dexamethasone suppression test</h6><br />The high-dose dexamethasone suppression test may be used to localise the pathology resulting in Cushing's syndrome. This test may be interpreted as follows:<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th>Cortisol</th><th>ACTH</th><th>Interpretation</th></tr></thead><tbody><tr><td>Not suppressed</td><td>Suppressed</td><td><span class=\"concept\" data-cid=\"11324\">Cushing's syndrome due to other causes (e.g. adrenal adenomas)</span></td></tr><tr><td> Suppressed</td><td>Suppressed</td><td><span class=\"concept\" data-cid=\"9806\">Cushing's disease</span> (i.e. <span class=\"concept\" data-cid=\"11325\">pituitary adenoma \u2192 ACTH secretion</span>)</td></tr><tr><td>Not suppressed</td><td>Not suppressed</td><td><span class=\"concept\" data-cid=\"11326\">Ectopic ACTH syndrome</span></td></tr></tbody></table></div><br /><h6 class='notes-subheading'>Other tests</h6><br />CRH stimulation<br /><ul><li>if pituitary source then cortisol rises</li><li>if ectopic/adrenal then no change in cortisol</li></ul><br />Petrosal sinus sampling of ACTH may be needed to differentiate between pituitary and ectopic ACTH secretion.<br /><br />An <span class=\"concept\" data-cid=\"1827\">insulin stress test</span> is used to differentiate between true Cushing's and pseudo-Cushing's.",
        "notes_hash": "195a1566a154d7314b7a91fb2e0b5adf",
        "knowledge_graph_node_id_link": 11298,
        "concept": "Cushing's syndrome - hypokalaemic metabolic alkalosis",
        "concept_percentile": "73",
        "concept_colour": "rgb(137,255,0)",
        "number_attempts": "5331",
        "up_votes": "34",
        "down_votes": "14",
        "column_array": [
            0,
            "875",
            "92",
            "1137",
            "3187",
            "40",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ZINZOob04IY\" data-description=\"Understanding The Dexamethasone Suppression Test\" data-upvotes=\"31\" data-downvotes=\"2\" data-media=\"500\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/ZINZOob04IY/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ZINZOob04IY\" data-description=\"Understanding The Dexamethasone Suppression Test\" data-upvotes=\"31\" data-downvotes=\"2\" data-media=\"500\">Understanding The Dexamethasone Suppression Test</a></td></tr><tr><td><span ><small>Zero to Finals - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_870\" data-mediaid=\"870\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_870\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">31</span><button type=\"button\" style=\"\" id=\"media_dislike_870\" data-mediaid=\"870\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_870\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/DvhLi6nNFu8\" data-description=\"Understanding Cushing's Syndrome\" data-upvotes=\"2\" data-downvotes=\"1\" data-media=\"1538\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/DvhLi6nNFu8/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/DvhLi6nNFu8\" data-description=\"Understanding Cushing's Syndrome\" data-upvotes=\"2\" data-downvotes=\"1\" data-media=\"1538\">Understanding Cushing's Syndrome</a></td></tr><tr><td><span ><small>Zero To Finals - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2689\" data-mediaid=\"2689\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2689\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">2</span><button type=\"button\" style=\"\" id=\"media_dislike_2689\" data-mediaid=\"2689\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2689\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ea1sXgd5ui8\" data-description=\"Cushing syndrome\" data-upvotes=\"9\" data-downvotes=\"5\" data-media=\"385\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/ea1sXgd5ui8/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ea1sXgd5ui8\" data-description=\"Cushing syndrome\" data-upvotes=\"9\" data-downvotes=\"5\" data-media=\"385\">Cushing syndrome</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_660\" data-mediaid=\"660\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_660\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">9</span><button type=\"button\" style=\"\" id=\"media_dislike_660\" data-mediaid=\"660\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_660\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">5</span></td></tr></table>",
        "comment_count": 2,
        "concepts_for_notes": {
            "150": {
                "concept_text": "Cushing's syndrome - hypokalaemic metabolic alkalosis",
                "concept_percentile": "73"
            },
            "151": {
                "concept_text": "The low-dose (overnight) dexamethasone suppression test is the best test to diagnosis Cushing's syndrome",
                "concept_percentile": "100"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_1663",
        "new_question_id": "5876",
        "question_type": "0",
        "category": "3",
        "concept_id_link": "493",
        "notes_id_link": "1_1941",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Prednisolone + fludrocortisone",
            "Hydrocortisone + fludrocortisone",
            "Hydrocortisone + dehydroepiandrosterone (DHEA)",
            "Prednisolone + spironolactone",
            "Hydrocortisone + oestrogen/progesterone",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 40-year-old woman is diagnosed as having Addison's disease. What combination of medications is she most likely to be prescribed?",
            "",
            ""
        ],
        "answers": [
            "2",
            "",
            ""
        ],
        "notes": [
            "The correct answer is <b>Hydrocortisone + fludrocortisone</b>. Addison's disease, also known as primary adrenal insufficiency, is a condition where the adrenal glands do not produce sufficient steroid hormones. The main hormones that are deficient are cortisol and aldosterone. Hydrocortisone is used to replace cortisol and fludrocortisone replaces aldosterone. This combination of medication helps to maintain the balance of these hormones in the body.<br /><br />The first incorrect option, <b>Prednisolone + fludrocortisone</b>, while it does include fludrocortisone for aldosterone replacement, prednisolone is not typically used as a first-line treatment for cortisol replacement in Addison's disease in the UK. Instead, hydrocortisone is preferred due to its closer resemblance to natural human cortisol.<br /><br />The next incorrect option, <b>Hydrocortisone + dehydroepiandrosterone (DHEA)</b>, includes hydrocortisone for cortisol replacement but DHEA is not a suitable substitute for aldosterone. DHEA is an endogenous steroid hormone but its role in treating Addison's disease has not been clearly established and it's generally not recommended.<br /><br /><b>Prednisolone + spironolactone</b> is another incorrect choice. Spironolactone acts as an aldosterone antagonist rather than a replacement, which could exacerbate symptoms of Addison's disease. Prednisolone, as mentioned before, isn't typically used for cortisol replacement in this context.<br /><br />Lastly, <b>Hydrocortisone + oestrogen/progesterone</b> would be inappropriate because while hydrocortisone can replace cortisol deficiency, neither oestrogen nor progesterone can replace the lack of aldosterone in Addison's disease patients.<br /><br />In summary, when managing patients with Addison's disease according to UK guidelines, hydrocortisone and fludrocortisones are most commonly prescribed to replace the deficient adrenal hormones.<br />",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 40-year-old woman is diagnosed as having Addison's disease. What combination of medications is she most likely to be prescribed?",
        "correct_answer": "2",
        "question_notes": "The correct answer is <b>Hydrocortisone + fludrocortisone</b>. Addison's disease, also known as primary adrenal insufficiency, is a condition where the adrenal glands do not produce sufficient steroid hormones. The main hormones that are deficient are cortisol and aldosterone. Hydrocortisone is used to replace cortisol and fludrocortisone replaces aldosterone. This combination of medication helps to maintain the balance of these hormones in the body.<br /><br />The first incorrect option, <b>Prednisolone + fludrocortisone</b>, while it does include fludrocortisone for aldosterone replacement, prednisolone is not typically used as a first-line treatment for cortisol replacement in Addison's disease in the UK. Instead, hydrocortisone is preferred due to its closer resemblance to natural human cortisol.<br /><br />The next incorrect option, <b>Hydrocortisone + dehydroepiandrosterone (DHEA)</b>, includes hydrocortisone for cortisol replacement but DHEA is not a suitable substitute for aldosterone. DHEA is an endogenous steroid hormone but its role in treating Addison's disease has not been clearly established and it's generally not recommended.<br /><br /><b>Prednisolone + spironolactone</b> is another incorrect choice. Spironolactone acts as an aldosterone antagonist rather than a replacement, which could exacerbate symptoms of Addison's disease. Prednisolone, as mentioned before, isn't typically used for cortisol replacement in this context.<br /><br />Lastly, <b>Hydrocortisone + oestrogen/progesterone</b> would be inappropriate because while hydrocortisone can replace cortisol deficiency, neither oestrogen nor progesterone can replace the lack of aldosterone in Addison's disease patients.<br /><br />In summary, when managing patients with Addison's disease according to UK guidelines, hydrocortisone and fludrocortisones are most commonly prescribed to replace the deficient adrenal hormones.<br />",
        "answer_order": "2",
        "answer": "2",
        "title": "Addison's disease: management",
        "body": "Patients who have Addison's disease are usually given both glucocorticoid and mineralocorticoid replacement therapy.<br /><br />This usually means that patients take a combination of:<br /><ul><li><span class=\"concept\" data-cid=\"493\">hydrocortisone</span>: usually given in 2 or 3 divided doses. Patients typically require 20-30 mg per day, with the <span class=\"concept\" data-cid=\"11256\">majority given in the first half of the day</span></li><li><span class=\"concept\" data-cid=\"493\">fludrocortisone</span></li></ul><br />Patient education is important:<br /><ul><li>emphasise the importance of not missing glucocorticoid doses</li><li>consider MedicAlert bracelets and steroid cards</li><li>patients should be provided with <span class=\"concept\" data-cid=\"2445\">hydrocortisone for injection</span> with needles and syringes to treat an adrenal crisis</li><li>discuss how to adjust the glucocorticoid dose during an intercurrent illness (see below)</li></ul><br />Management of intercurrent illness<br /><ul><li>in simple terms the <span class=\"concept\" data-cid=\"494\">glucocorticoid dose should be doubled, with the fludrocortisone dose staying the same</span></li><li>the Addison's Clinical Advisory Panel have produced guidelines detailing particular scenarios - please see the CKS link for more details</li></ul>",
        "notes_hash": "166e71d52791defe13da78d02e47e057",
        "knowledge_graph_node_id_link": 1122,
        "concept": "Addison's disease management - hydrocortisone + fludrocortisone",
        "concept_percentile": "45",
        "concept_colour": "rgb(255,229,0)",
        "number_attempts": "5738",
        "up_votes": "17",
        "down_votes": "12",
        "column_array": [
            0,
            "616",
            "4936",
            "66",
            "88",
            "32",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Royal College of Physicians</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_1320\" data-linkid=\"1320\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_1320\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">16</span><button type=\"button\" style=\"\" id=\"link_dislike_1320\" data-linkid=\"1320\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_1320\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">8</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.rcpjournals.org/content/clinmedicine/17/3/258\">2017 Adrenal insufficiency \u00e2\u20ac\u201c recognition and management </a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://upload.wikimedia.org/wikipedia/commons/c/c1/Primary_adrenal_insufficiency.webm\" data-description=\"Primary adrenal insufficiency (Addison's disease)\" data-upvotes=\"14\" data-downvotes=\"0\" data-media=\"107\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/css/images/osmosis.png\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://upload.wikimedia.org/wikipedia/commons/c/c1/Primary_adrenal_insufficiency.webm\" data-description=\"Primary adrenal insufficiency (Addison's disease)\" data-upvotes=\"14\" data-downvotes=\"0\" data-media=\"107\">Primary adrenal insufficiency (Addison's disease)</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_190\" data-mediaid=\"190\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_190\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">14</span><button type=\"button\" style=\"\" id=\"media_dislike_190\" data-mediaid=\"190\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_190\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/wqJUifWOGEo\" data-description=\"Addison's disease\" data-upvotes=\"10\" data-downvotes=\"0\" data-media=\"243\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/wqJUifWOGEo/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/wqJUifWOGEo\" data-description=\"Addison's disease\" data-upvotes=\"10\" data-downvotes=\"0\" data-media=\"243\">Addison's disease</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_408\" data-mediaid=\"408\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_408\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">10</span><button type=\"button\" style=\"\" id=\"media_dislike_408\" data-mediaid=\"408\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_408\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/1E0LcT-M1NY\" data-description=\"Understanding Adrenal Insufficiency\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"1687\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/1E0LcT-M1NY/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/1E0LcT-M1NY\" data-description=\"Understanding Adrenal Insufficiency\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"1687\">Understanding Adrenal Insufficiency</a></td></tr><tr><td><span ><small>Zero To Finals - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2862\" data-mediaid=\"2862\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2862\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0</span><button type=\"button\" style=\"\" id=\"media_dislike_2862\" data-mediaid=\"2862\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2862\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr></table>",
        "comment_count": 1,
        "concepts_for_notes": {
            "493": {
                "concept_text": "Addison's disease management - hydrocortisone + fludrocortisone",
                "concept_percentile": "45"
            },
            "494": {
                "concept_text": "Addison's patient with intercurrent illness --> double the glucocorticoids, keep fludrocortisone dose the same",
                "concept_percentile": "71"
            },
            "2445": {
                "concept_text": "Patients with Addison's should be given a hydrocortisone injection kit for adrenal crises",
                "concept_percentile": "79"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_4191",
        "new_question_id": "11901",
        "question_type": "0",
        "category": "9",
        "concept_id_link": "1213",
        "notes_id_link": "1_379",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Levodopa",
            "MAO-B inhibitor",
            "COMT inhibitor",
            "Dopamine antagonist",
            "Dopamine agonist",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 59-year-old man is diagnosed with Parkinson's disease after being referred with a tremor and bradykinesia. His symptoms are now affecting his ability to work as an accountant and are having a general impact on the quality of his life. What treatment is he most likely to be offered initially?",
            "",
            ""
        ],
        "answers": [
            "1",
            "0",
            "0"
        ],
        "notes": [
            "The correct answer is <b>Levodopa</b>. In the management of Parkinson's disease, Levodopa is considered the most effective treatment for motor symptoms such as tremor and bradykinesia. It is commonly used as a first-line therapy when symptoms significantly impact daily activities or work. Levodopa works by increasing dopamine concentrations in the brain, which helps to alleviate motor symptoms.<br /><br /><b>MAO-B inhibitor</b> is not the initial treatment for Parkinson's disease with significant functional impairment. MAO-B inhibitors, such as selegiline and rasagiline, work by inhibiting the enzyme monoamine oxidase B (MAO-B) that breaks down dopamine in the brain. They can help to improve motor symptoms but are usually less effective than Levodopa. MAO-B inhibitors are generally used for early-stage Parkinson's disease when symptoms are mild and do not significantly affect daily activities.<br /><br /><b>COMT inhibitor</b> is also not recommended as an initial treatment for significant functional impairment due to Parkinson's disease. COMT inhibitors, such as entacapone and tolcapone, block catechol-O-methyltransferase (COMT), an enzyme involved in breaking down dopamine. These medications are typically used in combination with Levodopa to prolong its effect and reduce motor fluctuations experienced by some patients on long-term Levodopa therapy.<br /><br />A <b>dopamine antagonist</b> would be an inappropriate choice for treating Parkinson's disease, as it would worsen the patient's condition rather than improve it. Dopamine antagonists work by blocking dopamine receptors in the brain, which would further decrease dopamine activity and exacerbate motor symptoms.<br /><br />Finally, a <b>dopamine agonist</b>, such as pramipexole or ropinirole, could be considered an alternative initial treatment option for some patients with Parkinson's disease; however, it is less likely to be offered initially in this case. Dopamine agonists directly stimulate dopamine receptors, mimicking the effects of dopamine. They are generally used for younger patients or those with mild symptoms as they have a lower risk of motor complications compared to Levodopa. In this scenario, the patient's symptoms are significantly affecting his ability to work and his quality of life, making Levodopa the most appropriate initial treatment option.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 59-year-old man is diagnosed with Parkinson's disease after being referred with a tremor and bradykinesia. His symptoms are now affecting his ability to work as an accountant and are having a general impact on the quality of his life. What treatment is he most likely to be offered initially?",
        "correct_answer": "1",
        "question_notes": "The correct answer is <b>Levodopa</b>. In the management of Parkinson's disease, Levodopa is considered the most effective treatment for motor symptoms such as tremor and bradykinesia. It is commonly used as a first-line therapy when symptoms significantly impact daily activities or work. Levodopa works by increasing dopamine concentrations in the brain, which helps to alleviate motor symptoms.<br /><br /><b>MAO-B inhibitor</b> is not the initial treatment for Parkinson's disease with significant functional impairment. MAO-B inhibitors, such as selegiline and rasagiline, work by inhibiting the enzyme monoamine oxidase B (MAO-B) that breaks down dopamine in the brain. They can help to improve motor symptoms but are usually less effective than Levodopa. MAO-B inhibitors are generally used for early-stage Parkinson's disease when symptoms are mild and do not significantly affect daily activities.<br /><br /><b>COMT inhibitor</b> is also not recommended as an initial treatment for significant functional impairment due to Parkinson's disease. COMT inhibitors, such as entacapone and tolcapone, block catechol-O-methyltransferase (COMT), an enzyme involved in breaking down dopamine. These medications are typically used in combination with Levodopa to prolong its effect and reduce motor fluctuations experienced by some patients on long-term Levodopa therapy.<br /><br />A <b>dopamine antagonist</b> would be an inappropriate choice for treating Parkinson's disease, as it would worsen the patient's condition rather than improve it. Dopamine antagonists work by blocking dopamine receptors in the brain, which would further decrease dopamine activity and exacerbate motor symptoms.<br /><br />Finally, a <b>dopamine agonist</b>, such as pramipexole or ropinirole, could be considered an alternative initial treatment option for some patients with Parkinson's disease; however, it is less likely to be offered initially in this case. Dopamine agonists directly stimulate dopamine receptors, mimicking the effects of dopamine. They are generally used for younger patients or those with mild symptoms as they have a lower risk of motor complications compared to Levodopa. In this scenario, the patient's symptoms are significantly affecting his ability to work and his quality of life, making Levodopa the most appropriate initial treatment option.",
        "answer_order": "1",
        "answer": "1",
        "title": "Parkinson's disease: management",
        "body": "Parkinsons disease should only be diagnosed, and management initiated, by a <span class=\"concept\" data-cid=\"5645\">specialist</span> with expertise in movement disorders. However, it is important for all doctors to be aware of the medications used in Parkinson's given the prevalence of this condition. NICE published guidelines in 2017 regarding the management of Parkinson's disease.<br /><br />For first-line treatment:<br /><ul><li>if the motor symptoms are affecting the patient's quality of life: <span class=\"concept\" data-cid=\"1213\">levodopa</span></li><li>if the motor symptoms are not affecting the patient's quality of life: dopamine agonist (non-ergot derived), levodopa or monoamine oxidase B (MAO-B) inhibitor</li></ul><br />Whilst all drugs used to treat Parkinson's can cause a wide variety of side-effects NICE produced tables to help with decision making:<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th></th><th>Levodopa</th><th>Dopamine agonists</th><th>MAO-B inhibitors</th></tr></thead><tbody><tr><td><b>Motor symptoms</b></td><td><span class=\"concept\" data-cid=\"1214\">More improvement in motor symptoms</span></td><td>Less improvement in motor symptoms</td><td>Less improvement in motor symptoms</td></tr><tr><td><b>Activities of daily living</b></td><td><span class=\"concept\" data-cid=\"1214\">More improvement in activities of daily living</span></td><td>Less improvement in activities of daily living</td><td>Less improvement in activities of daily living</td></tr><tr><td><b>Motor complications</b></td><td>More motor complications</td><td>Fewer motor complications</td><td>Fewer motor complications</td></tr><tr><td><b>Adverse events</b></td><td>Fewer specified adverse events*</td><td>More specified adverse events*</td><td>Fewer specified adverse events*</td></tr></tbody></table></div>* excessive sleepiness, <span class=\"concept\" data-cid=\"4334\">hallucinations</span> and impulse control disorders<br /><br />If a patient continues to have symptoms despite optimal levodopa treatment or has developed dyskinesia then NICE recommend the addition of a dopamine agonist, MAO-B inhibitor or catechol-O-methyl transferase (COMT) inhibitor as an adjunct. Again, NICE summarise the main points in terms of decision making:<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid2\" ><thead><tr><th></th><th>Dopamine agonists</th><th>MAO-B inhibitors</th><th>COMT inhibitors</th><th>Amantadine</th></tr></thead><tbody><tr><td><b>Motor symptoms</b></td><td>Improvement in motor symptoms</td><td>Improvement in motor symptoms</td><td>Improvement in motor symptoms</td><td>No evidence of improvement in motor symptoms</td></tr><tr><td><b>Activities of daily living</b></td><td>Improvement in activities of daily living</td><td>Improvement in activities of daily living</td><td>Improvement in activities of daily living</td><td>No evidence of improvement in activities of daily living</td></tr><tr><td><b>Off time</b></td><td>More off-time reduction</td><td>Off-time reduction</td><td>Off-time reduction</td><td>No studies reporting this outcome</td></tr><tr><td><b>Adverse events</b></td><td>Intermediate risk of adverse events</td><td>Fewer adverse events</td><td>More adverse events</td><td>No studies reporting this outcome</td></tr><tr><td><b>Hallucinations</b></td><td><span class=\"concept\" data-cid=\"4334\">More risk of hallucinations</span></td><td>Lower risk of hallucinations</td><td>Lower risk of hallucinations</td><td>No studies reporting this outcome</td></tr></tbody></table></div><br /><br /><h5 class='notes-heading'>Specific points regarding Parkinson's medication</h5><br />NICE reminds us of the risk of acute akinesia or neuroleptic malignant syndrome if medication is not taken/absorbed (for example due to gastroenteritis) and advise against giving patients a 'drug holiday' for the same reason.<br /><br />Impulse control disorders have become a significant issue in recent years. These can occur with any dopaminergic therapy but are more common with:<br /><ul><li><span class=\"concept\" data-cid=\"5640\">dopamine agonist therapy</span></li><li>a history of previous impulsive behaviours</li><li>a history of alcohol consumption and/or smoking</li></ul><br />If excessive daytime sleepiness develops then patients should not drive. Medication should be adjusted to control symptoms. Modafinil can be considered if alternative strategies fail.<br /><br />If orthostatic hypotension develops then a medication review looking at potential causes should be done. If symptoms persist then midodrine (acts on peripheral alpha-adrenergic receptors to increase arterial resistance) can be considered.<br /><br /><span class=\"concept\" data-cid=\"9533\">Consider glycopyrronium bromide to manage drooling of saliva in people with Parkinson's disease.</span><br /><br /><h5 class='notes-heading'>Further information regarding specific anti-Parkinson's medication</h5><br /><br />Levodopa<br /><ul><li>nearly always combined with a decarboxylase inhibitor (e.g. carbidopa or benserazide)<ul><li>this prevents the peripheral metabolism of levodopa to dopamine outside of the brain and hence can reduce side effects</li></ul></li><li>common adverse effects: <ul><li><span class=\"concept\" data-cid=\"6272\">dry mouth</span></li><li><span class=\"concept\" data-cid=\"6273\">anorexia</span></li><li><span class=\"concept\" data-cid=\"6274\">palpitations</span></li><li><span class=\"concept\" data-cid=\"6275\">postural hypotension</span></li><li><span class=\"concept\" data-cid=\"6276\">psychosis</span></li></ul></li><li>some adverse effects are due to the difficulty in achieving a steady dose of levodopa<ul><li><span class=\"concept\" data-cid=\"11755\">end-of-dose wearing off</span>: symptoms often worsen towards the end of dosage interval. This results in a decline of motor activity</li><li><span class=\"concept\" data-cid=\"11756\">'on-off' phenomenon</span>: large variations in motor performance, with normal function during the 'on' period, and weakness and restricted mobility during the 'off' period</li><li><span class=\"concept\" data-cid=\"6277\">dyskinesias at peak dose: dystonia, chorea and athetosis (involuntary writhing movements)</span></li><li>these effects may worsen over time with - clinicians therefore may limit doses until necessary</li></ul></li><li>it is important <span class=\"concept\" data-cid=\"5641\">not to acutely stop levodopa</span>, for example, if a patient is admitted to hospital<ul><li>if a patient with Parkinson's disease cannot take levodopa orally, they can be given a dopamine agonist patch as <span class=\"concept\" data-cid=\"5643\">rescue medication</span> to prevent acute dystonia</li></ul></li></ul><br />Dopamine receptor agonists<br /><ul><li>e.g. <span class=\"concept\" data-cid=\"6282\">bromocriptine</span>, <span class=\"concept\" data-cid=\"665\">ropinirole</span>, <span class=\"concept\" data-cid=\"6284\">cabergoline</span>, <span class=\"concept\" data-cid=\"6285\">apomorphine</span></li><li>ergot-derived dopamine receptor agonists (bromocriptine, cabergoline) have been associated with <span class=\"concept\" data-cid=\"6278\">pulmonary, retroperitoneal and cardiac fibrosis</span>. The Committee on Safety of Medicines advice that an echocardiogram, ESR, creatinine and chest x-ray should be obtained prior to treatment and patients should be closely monitored</li><li>patients should be warned about the potential for dopamine receptor agonists to cause impulse control disorders and excessive daytime somnolence</li><li>more likely than levodopa to cause hallucinations in older patients. Nasal congestion and postural hypotension are also seen in some patients</li></ul> <br />MAO-B (Monoamine Oxidase-B) inhibitors<br /><ul><li>e.g. <span class=\"concept\" data-cid=\"6286\">selegiline</span></li><li>inhibits the breakdown of dopamine secreted by the dopaminergic neurons</li></ul><br />Amantadine<br /><ul><li>mechanism is not fully understood, probably increases dopamine release and inhibits its uptake at dopaminergic synapses</li><li>side-effects include <span class=\"concept\" data-cid=\"6302\">ataxia</span>, <span class=\"concept\" data-cid=\"6303\">slurred speech</span>, <span class=\"concept\" data-cid=\"6304\">confusion</span>, <span class=\"concept\" data-cid=\"6305\">dizziness</span> and <span class=\"concept\" data-cid=\"6306\">livedo reticularis</span></li></ul><br />COMT (Catechol-O-Methyl Transferase) inhibitors<br /><ul><li>e.g. <span class=\"concept\" data-cid=\"6287\">entacapone</span>, <span class=\"concept\" data-cid=\"6291\">tolcapone</span></li><li>COMT is an enzyme involved in the breakdown of dopamine, and hence may be used as an adjunct to levodopa therapy</li><li>used in conjunction with levodopa in patients with established PD</li></ul><br />Antimuscarinics<br /><ul><li>block cholinergic receptors</li><li>now used more to treat drug-induced parkinsonism rather than idiopathic Parkinson's disease</li><li>help tremor and rigidity</li><li>e.g. <span class=\"concept\" data-cid=\"6290\">procyclidine</span>, <span class=\"concept\" data-cid=\"6289\">benzotropine</span>, trihexyphenidyl (<span class=\"concept\" data-cid=\"6288\">benzhexol</span>)</li></ul><br /><CENTER><table><tr><td align = 'left' colspan='2'><a data-fancybox class='fancybox' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/swb025b.jpg'><img class='ajaximage' src='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/swb025.jpg'/></a></td></tr><tr><td valign='top' align='left'> <span style = 'font-size:11px; color:LightGray;'>Image sourced from </span><a href='https://en.wikipedia.org/wiki/Main_Page'  target='_blank' style = 'font-size:11px; color:LightGray;' >Wikipedia</a></td><td align='right'><a data-fancybox class='fancybox lbmagglasslink' rel='group' href='https://d32xxyeh8kfs8k.cloudfront.net/images_Passmedicine/swb025b.jpg'><img src='https://d32xxyeh8kfs8k.cloudfront.net/css/images/mag_glass.png'/></a></td></tr></table></CENTER><div class='imagetext'>Diagram showing the mechanism of action of Parkinson's drugs<br /></div>",
        "notes_hash": "522482862f1c510c228543b95ca1ada0",
        "knowledge_graph_node_id_link": 1019,
        "concept": "Levodopa should be offered for patients with newly diagnosed Parkinson's who have motor symptoms affecting their quality of life",
        "concept_percentile": "95",
        "concept_colour": "rgb(25,255,0)",
        "number_attempts": "6032",
        "up_votes": "25",
        "down_votes": "12",
        "column_array": [
            0,
            "4873",
            "114",
            "49",
            "161",
            "835",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>NICE</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_261\" data-linkid=\"261\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_261\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">24</span><button type=\"button\" style=\"\" id=\"link_dislike_261\" data-linkid=\"261\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_261\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">18</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.nice.org.uk/guidance/ng71/chapter/Recommendations\">2017 Parkinson's disease guidelines</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Z84iypHdftQ\" data-description=\"Pharmacology - DRUGS FOR PARKINSON'S DISEASE\" data-upvotes=\"27\" data-downvotes=\"0\" data-media=\"1069\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/Z84iypHdftQ/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Z84iypHdftQ\" data-description=\"Pharmacology - DRUGS FOR PARKINSON'S DISEASE\" data-upvotes=\"27\" data-downvotes=\"0\" data-media=\"1069\">Pharmacology - DRUGS FOR PARKINSON'S DISEASE</a></td></tr><tr><td><span ><small>Speed Pharmacology - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1863\" data-mediaid=\"1863\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1863\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">27</span><button type=\"button\" style=\"\" id=\"media_dislike_1863\" data-mediaid=\"1863\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1863\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/_pZmMU2xLM8\" data-description=\"Understanding Parkinson's Disease\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"1364\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/_pZmMU2xLM8/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/_pZmMU2xLM8\" data-description=\"Understanding Parkinson's Disease\" data-upvotes=\"0\" data-downvotes=\"0\" data-media=\"1364\">Understanding Parkinson's Disease</a></td></tr><tr><td><span ><small>Rhesus Medicine - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2396\" data-mediaid=\"2396\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2396\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0</span><button type=\"button\" style=\"\" id=\"media_dislike_2396\" data-mediaid=\"2396\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2396\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/iO-M7jq-zuY\" data-description=\"Pharmacology - Parkinson's Disease\" data-upvotes=\"6\" data-downvotes=\"1\" data-media=\"276\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/iO-M7jq-zuY/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/iO-M7jq-zuY\" data-description=\"Pharmacology - Parkinson's Disease\" data-upvotes=\"6\" data-downvotes=\"1\" data-media=\"276\">Pharmacology - Parkinson's Disease</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_471\" data-mediaid=\"471\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_471\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">6</span><button type=\"button\" style=\"\" id=\"media_dislike_471\" data-mediaid=\"471\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_471\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Mz_tEu835Yg\" data-description=\"Parkinson's disease pharmacology\" data-upvotes=\"5\" data-downvotes=\"1\" data-media=\"312\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/Mz_tEu835Yg/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Mz_tEu835Yg\" data-description=\"Parkinson's disease pharmacology\" data-upvotes=\"5\" data-downvotes=\"1\" data-media=\"312\">Parkinson's disease pharmacology</a></td></tr><tr><td><span ><small>Soton Brain Hub - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_531\" data-mediaid=\"531\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_531\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">5</span><button type=\"button\" style=\"\" id=\"media_dislike_531\" data-mediaid=\"531\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_531\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Zg5o8Mn5g-Q\" data-description=\"The use of Levodopa/ Carbidopa in the treatment of Parkinson's disease\" data-upvotes=\"8\" data-downvotes=\"2\" data-media=\"687\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/Zg5o8Mn5g-Q/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/Zg5o8Mn5g-Q\" data-description=\"The use of Levodopa/ Carbidopa in the treatment of Parkinson's disease\" data-upvotes=\"8\" data-downvotes=\"2\" data-media=\"687\">The use of Levodopa/ Carbidopa in the treatment of Parkinson's disease</a></td></tr><tr><td><span ><small>Medicosis Perfectionalis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1184\" data-mediaid=\"1184\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1184\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">8</span><button type=\"button\" style=\"\" id=\"media_dislike_1184\" data-mediaid=\"1184\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1184\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ARdGaE1sbBM\" data-description=\"Parkinson's disease\" data-upvotes=\"3\" data-downvotes=\"2\" data-media=\"5\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/ARdGaE1sbBM/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/ARdGaE1sbBM\" data-description=\"Parkinson's disease\" data-upvotes=\"3\" data-downvotes=\"2\" data-media=\"5\">Parkinson's disease</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_12\" data-mediaid=\"12\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_12\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">3</span><button type=\"button\" style=\"\" id=\"media_dislike_12\" data-mediaid=\"12\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_12\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">2</span></td></tr></table>",
        "comment_count": 2,
        "concepts_for_notes": {
            "1213": {
                "concept_text": "Levodopa should be offered for patients with newly diagnosed Parkinson's who have motor symptoms affecting their quality of life",
                "concept_percentile": "95"
            },
            "4334": {
                "concept_text": "Parkinson's disease medications: dopamine agonists have a higher risk of hallucinations compared to the other classes of medications",
                "concept_percentile": "88"
            },
            "6272": {
                "concept_text": "Levodopa may cause dry mouth",
                "concept_percentile": "14"
            },
            "6273": {
                "concept_text": "Levodopa may cause anorexia",
                "concept_percentile": "4"
            },
            "6274": {
                "concept_text": "Levodopa may cause palpitations",
                "concept_percentile": "10"
            },
            "6275": {
                "concept_text": "Levodopa may cause postural hypotension",
                "concept_percentile": "14"
            },
            "6276": {
                "concept_text": "Levodopa may cause psychosis",
                "concept_percentile": "18"
            },
            "6277": {
                "concept_text": "Patients taking levodopa may experience dyskinesias at peak dose: dystonia, chorea and athetosis (involuntary writhing movements)",
                "concept_percentile": "41"
            },
            "6278": {
                "concept_text": "Bromocriptine may cause pulmonary, retroperitoneal and cardiac fibrosis",
                "concept_percentile": "7"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "10510_B_254",
        "new_question_id": "32326",
        "question_type": "0",
        "category": "2",
        "concept_id_link": "10693",
        "notes_id_link": "1_329",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "Acute angle-closure glaucoma",
            "Dry age-related macular degeneration",
            "Retinal detachment",
            "Vitreous haemorrhage",
            "Wet age-related macular degeneration",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 72-year-old man is referred to ophthalmology complaining of worsening vision. He says that he has noticed his vision gradually getting worse over the last few months, but feels that it has suddenly deteriorated further in the last week. Visual field testing reveals a central scotoma and there are well-demarcated red patches on the retina on fundoscopy.<br /><br />Which of the following is the most likely diagnosis?",
            "",
            ""
        ],
        "answers": [
            "5",
            "0",
            "0"
        ],
        "notes": [
            "The correct answer is wet age-related macular degeneration (ARMD).<br /><br />This patient is presenting with features typical of wet ARMD. They have had steadily worsening loss of vision over the previous few months, followed by a sudden deterioration. The examination findings of a central scotoma and red patches on the retina on fundoscopy are also typical of wet ARMD.<br /><br />Acute angle-closure glaucoma would typically present with a severe headache and visual disturbance, accompanied by vomiting. In contrast to this patient, the pupils of affected eyes in acute glaucoma are often mid-dilated and fixed, or an irregular pupil shape may be present.<br /><br />Dry ARMD would also present with a slow decrease in vision over a few months, however, it is less likely to present with a sudden further deterioration like in this patient. Additionally, you would not see the red patches on the retina, which represent leakage of serous fluid and blood.<br /><br />Retinal detachment is a cause of sudden, painless loss of vision. It would typically present as a dense shadow that starts peripherally and progresses centrally. It may progress from posterior vitreous detachment, and so patients may complain of flashes and floaters in their vision before retinal detachment occurs.<br /><br />Vitreous haemorrhage is a common cause of sudden visual loss in diabetics. It typically presents with acute onset, painless loss of vision. Patients may complain of dark spots in their vision. Fundoscopy typically shows a haemorrhage within the vitreous cavity.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 72-year-old man is referred to ophthalmology complaining of worsening vision. He says that he has noticed his vision gradually getting worse over the last few months, but feels that it has suddenly deteriorated further in the last week. Visual field testing reveals a central scotoma and there are well-demarcated red patches on the retina on fundoscopy.<br /><br />Which of the following is the most likely diagnosis?",
        "correct_answer": "5",
        "question_notes": "The correct answer is wet age-related macular degeneration (ARMD).<br /><br />This patient is presenting with features typical of wet ARMD. They have had steadily worsening loss of vision over the previous few months, followed by a sudden deterioration. The examination findings of a central scotoma and red patches on the retina on fundoscopy are also typical of wet ARMD.<br /><br />Acute angle-closure glaucoma would typically present with a severe headache and visual disturbance, accompanied by vomiting. In contrast to this patient, the pupils of affected eyes in acute glaucoma are often mid-dilated and fixed, or an irregular pupil shape may be present.<br /><br />Dry ARMD would also present with a slow decrease in vision over a few months, however, it is less likely to present with a sudden further deterioration like in this patient. Additionally, you would not see the red patches on the retina, which represent leakage of serous fluid and blood.<br /><br />Retinal detachment is a cause of sudden, painless loss of vision. It would typically present as a dense shadow that starts peripherally and progresses centrally. It may progress from posterior vitreous detachment, and so patients may complain of flashes and floaters in their vision before retinal detachment occurs.<br /><br />Vitreous haemorrhage is a common cause of sudden visual loss in diabetics. It typically presents with acute onset, painless loss of vision. Patients may complain of dark spots in their vision. Fundoscopy typically shows a haemorrhage within the vitreous cavity.",
        "answer_order": "5",
        "answer": "5",
        "title": "Age-related macular degeneration",
        "body": "Age-related macular degeneration is the most common cause of blindness in the UK. Degeneration of the central retina (macula) is the key feature with changes usually bilateral. ARMD is characterised by degeneration of retinal photoreceptors that results in the formation of drusen which can be seen on fundoscopy and retinal photography. It is more common with advancing age and is more common in females.<br /><br />Risk factors<br /><ul><li>advancing age itself is the greatest risk factor for ARMD<ul><li>the risk of ARMD increases 3 fold for patients aged older than 75 years, versus those aged 65-74.</li></ul></li><li><span class=\"concept\" data-cid=\"640\">smoking</span><ul><li>current smokers are twice as likely as non-smokers to have ARMD related visual loss, and ex-smokers have a slightly increased risk of developing the condition, (OR 1.13). </li></ul></li><li>family history is also a strong risk factor for developing ARMD<ul><li>first degree relatives of a sufferer of ARMD are thought to be four times more likely to inherit the condition.</li></ul></li><li>other risk factors for developing the condition include those associated with an increased risk of ischaemic cardiovascular disease, such as hypertension, dyslipidaemia and diabetes mellitus. </li></ul><br /><br /><h5 class='notes-heading'>Classification</h5><br />Traditionally two forms of macular degeneration are seen:<br /><ul><li>dry macular degeneration<ul><li>90% of cases</li><li>also known as atrophic</li><li>characterised by <span class=\"concept\" data-cid=\"639\">drusen</span>  - yellow round spots in Bruch's membrane</li></ul></li><li>wet macular degeneration<ul><li>10% of cases</li><li>also known as exudative or neovascular macular degeneration</li><li>characterised by <span class=\"concept\" data-cid=\"11900\">choroidal neovascularisation</span></li><li>leakage of serous fluid and blood can subsequently result in a rapid loss of vision</li><li>carries the worst prognosis</li></ul></li></ul><br />Recently there has been a move to a more updated classification:<br /><ul><li>early age-related macular degeneration (non-exudative, age-related maculopathy): drusen and alterations to the retinal pigment epithelium (RPE)</li><li>late age-related macular degeneration (neovascularisation, exudative)</li></ul><br /><h5 class='notes-heading'>Clinical features</h5><br />Patients typically present with a subacute onset of visual loss with:<br /><ul><li>a reduction in visual acuity, particularly for near field objects<ul><li>gradual in dry ARMD </li><li>subacute in wet ARMD</li></ul></li><li><span class=\"concept\" data-cid=\"12500\">worse in the centre of vision</span> (e.g. difficulty reading, recognising faces, driving)</li><li>difficulties in dark adaptation with an overall deterioration in vision at night</li><li>fluctuations in visual disturbance which may vary significantly from day to day</li><li>they may also suffer from photopsia, (a perception of flickering or flashing lights), and glare around objects</li><li>visual hallucinations may also occur resulting in Charles-Bonnet syndrome</li></ul><br />Signs:<br /><ul><li>distortion of line perception may be noted on <span class=\"concept\" data-cid=\"11392\">Amsler grid testing</span></li><li>fundoscopy reveals the presence of drusen, yellow areas of pigment deposition in the macular area, which may become confluent in late disease to form a macular scar.</li><li>in wet ARMD well demarcated red patches may be seen which represent intra-retinal or sub-retinal fluid leakage or haemorrhage. </li></ul>   <br />Investigations:<br /><ul><li>slit-lamp microscopy is the initial investigation of choice, to identify any pigmentary, exudative or haemorrhagic changes affecting the retina which may identify the presence of ARMD. This is usually accompanied by colour fundus photography to provide a baseline against which changes can be identified over time.</li><li>fluorescein angiography is utilised if neovascular ARMD is suspected, as this can guide intervention with anti-VEGF therapy. This may be complemented with indocyanine green angiography to visualise any changes in the choroidal circulation. </li><li>optical coherence tomography is used to visualise the retina in three dimensions because it can reveal areas of disease which aren't visible using microscopy alone. </li></ul><br /><h5 class='notes-heading'>Management</h5><br />Treatment<br /><ul><li>the AREDS trial examined the treatment of dry ARMD in 3640 subjects. It showed that a combination of zinc with anti-oxidant vitamins A,C and E reduced progression of the disease by around one third. Patients with more extensive drusen seemed to benefit most from the intervention. Treatment is therefore recommended in patients with at least moderate category dry ARMD. </li><li><span class=\"concept\" data-cid=\"4069\">vascular endothelial growth factor (VEGF)</span> <ul><li>VEGR is a potent mitogen and drives increased vascular permeability in patients with wet ARMD</li><li>a number of trials have shown that use of anti-VEGF agents can limit progression of wet ARMD and stabilise or reverse visual loss</li><li>evidence suggests that they should be instituted within the first two months of diagnosis of wet ARMD if possible</li><li>examples of anti-VEGF agents include ranibizumab, <span class=\"concept\" data-cid=\"11448\">bevacizumab</span> and pegaptanib,. The agents are usually administered by 4 weekly injection. </li></ul></li><li>laser photocoagulation does slow progression of ARMD where there is new vessel formation, although there is a risk of acute visual loss after treatment, which may be increased in patients with sub-foveal ARMD. For this reason anti-VEGF therapies are usually preferred.</li></ul>",
        "notes_hash": "09af800e13bb1ef3f1990b7d53bc66af",
        "knowledge_graph_node_id_link": 1286,
        "concept": "Decreasing vision over months with metamorphopsia and central scotoma should cause high suspicion of wet age-related macular degeneration",
        "concept_percentile": "93",
        "concept_colour": "rgb(35,255,0)",
        "number_attempts": "6145",
        "up_votes": "30",
        "down_votes": "20",
        "column_array": [
            0,
            "156",
            "1338",
            "320",
            "1189",
            "3142",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Webvision</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_410\" data-linkid=\"410\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_410\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">42</span><button type=\"button\" style=\"\" id=\"link_dislike_410\" data-linkid=\"410\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_410\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">42</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://webvision.med.utah.edu/book/part-xii-cell-biology-of-retinal-degenerations/age-related-macular-degeneration-amd/\">Age related macular degeneration fundoscopy findings</a></td></tr></table>",
        "media": "",
        "comment_count": 4,
        "concepts_for_notes": {
            "639": {
                "concept_text": "<b>D</b>rusen = <b>D</b>ry macular degeneration",
                "concept_percentile": "67"
            },
            "640": {
                "concept_text": "Macular degeneration - smoking is risk factor",
                "concept_percentile": "80"
            },
            "11392": {
                "concept_text": "Amsler grid testing (to check for distortion of line perception) may be useful in testing patients with suspected age related macular degeneration",
                "concept_percentile": "85"
            },
            "12500": {
                "concept_text": "Elderly patient, gradual, central visual loss --> age-related macular degeneration",
                "concept_percentile": "100"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_B_9329",
        "new_question_id": "3615",
        "question_type": "0",
        "category": "4",
        "concept_id_link": "354",
        "notes_id_link": "1_162",
        "theme": "",
        "instruction": "",
        "options": [
            "",
            "0%",
            "25%",
            "50% if female, 0% if male",
            "50% if male, 0% if female",
            "50%",
            "",
            "",
            "",
            "",
            ""
        ],
        "num_of_options": 5,
        "questions": [
            "A 35-year-old man is investigated for lethargy, arthralgia and deranged liver function tests. He is eventually diagnosed as having hereditary hemochromatosis. His wife has a genetic test which shows she is not a carrier of the disease. What is the chance his child will develop haemochromatosis?",
            "",
            ""
        ],
        "answers": [
            "1",
            "",
            ""
        ],
        "notes": [
            "Haemochromatosis is an autosomal recessive condition. If one of the parents has haemochromatosis (i.e. is homozygous) and the other is not a carrier/affected then all the children will inherit one copy of the gene from the affected parent and hence will be carriers.",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 35-year-old man is investigated for lethargy, arthralgia and deranged liver function tests. He is eventually diagnosed as having hereditary hemochromatosis. His wife has a genetic test which shows she is not a carrier of the disease. What is the chance his child will develop haemochromatosis?",
        "correct_answer": "1",
        "question_notes": "Haemochromatosis is an autosomal recessive condition. If one of the parents has haemochromatosis (i.e. is homozygous) and the other is not a carrier/affected then all the children will inherit one copy of the gene from the affected parent and hence will be carriers.",
        "answer_order": "1",
        "answer": "1",
        "title": "Haemochromatosis: features",
        "body": "Haemochromatosis is an <span class=\"concept\" data-cid=\"354\">autosomal recessive</span> disorder of iron absorption and metabolism resulting in iron accumulation. It is caused by inheritance of mutations in the HFE gene on both copies of <span class=\"concept\" data-cid=\"8430\">chromosome 6</span>*. It is often asymptomatic in early disease and initial symptoms often non-specific e.g. lethargy and arthralgia<br /><br />Epidemiology<br /><ul><li>1 in 10 people of European descent carry a mutation in the genes affecting iron metabolism, mainly HFE</li><li>prevalence in people of European descent = 1 in 200, making it <span class=\"concept\" data-cid=\"354\">more common than cystic fibrosis</span></li></ul><br />Presenting features<br /><ul><li>early symptoms include <span class=\"concept\" data-cid=\"4457\">fatigue, erectile dysfunction and arthralgia (often of the hands)</span></li><li><span class=\"concept\" data-cid=\"3415\">'bronze' skin pigmentation</span></li><li><span class=\"concept\" data-cid=\"8427\">diabetes mellitus</span></li><li>liver: stigmata of chronic liver disease, hepatomegaly, cirrhosis, hepatocellular deposition)</li><li>cardiac failure (2nd to <span class=\"concept\" data-cid=\"8428\">dilated cardiomyopathy</span>)</li><li>hypogonadism (2nd to cirrhosis and pituitary dysfunction - hypogonadotrophic hypogonadism)</li><li><span class=\"concept\" data-cid=\"8429\">arthritis</span> (especially of the hands)</li></ul><br />Questions have previously been asked regarding which features are reversible with treatment:<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th><b><span class=\"concept\" data-cid=\"8431\">Reversible complications</span></b></th><th><b>Irreversible complications</b></th></tr></thead><tbody><tr><td><ul><li>Cardiomyopathy</li><li>Skin pigmentation</li></ul></td><td><ul><li>Liver cirrhosis**</li><li>Diabetes mellitus</li><li>Hypogonadotrophic hypogonadism</li><li>Arthropathy</td></tr></tbody></table></div></li></ul><br />*there are rare cases of families with classic features of genetic haemochromatosis but no mutation in the HFE gene<br />**whilst elevated liver function tests and hepatomegaly may be reversible, cirrhosis is not",
        "notes_hash": "bdfd83e4933d9dfedc521ef00fdb5781",
        "knowledge_graph_node_id_link": 1197,
        "concept": "Haemochromatosis is autosomal recessive",
        "concept_percentile": "47",
        "concept_colour": "rgb(255,239,0)",
        "number_attempts": "5837",
        "up_votes": "61",
        "down_votes": "23",
        "column_array": [
            0,
            "2418",
            "1400",
            "311",
            "464",
            "1244",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "<table style='width:100%'><tr><td>Medcomic</td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"link_like_2056\" data-linkid=\"2056\" data-rating=\"1\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"link_good_count_2056\" class = \"link_good_count\" style=\"color:green; font-size:85%;\">17</span><button type=\"button\" style=\"\" id=\"link_dislike_2056\" data-linkid=\"2056\" data-rating=\"0\" class=\"rate-link btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"link_bad_count_2056\" class = \"link_bad_count\" style=\"color:red; font-size:85%;\">8</span></td></tr><tr><td colspan=\"2\"><a target=\"_blank\" href=\"https://www.medcomic.com/medcomic/hereditary-hemochromatosis-vs-wilson-disease\">Hereditary Hemochromatosis vs. Wilson Disease</a></td></tr></table>",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/36n37AaVVLc\" data-description=\"Haemochromatosis\" data-upvotes=\"14\" data-downvotes=\"0\" data-media=\"878\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/36n37AaVVLc/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/36n37AaVVLc\" data-description=\"Haemochromatosis\" data-upvotes=\"14\" data-downvotes=\"0\" data-media=\"878\">Haemochromatosis</a></td></tr><tr><td><span ><small>Zero to Finals - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_1538\" data-mediaid=\"1538\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_1538\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">14</span><button type=\"button\" style=\"\" id=\"media_dislike_1538\" data-mediaid=\"1538\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_1538\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://upload.wikimedia.org/wikipedia/commons/1/15/Hemochromatosis.webm\" data-description=\"Haemochromatosis\" data-upvotes=\"3\" data-downvotes=\"0\" data-media=\"40\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://d32xxyeh8kfs8k.cloudfront.net/css/images/osmosis.png\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://upload.wikimedia.org/wikipedia/commons/1/15/Hemochromatosis.webm\" data-description=\"Haemochromatosis\" data-upvotes=\"3\" data-downvotes=\"0\" data-media=\"40\">Haemochromatosis</a></td></tr><tr><td><span ><small>Osmosis - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_69\" data-mediaid=\"69\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_69\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">3</span><button type=\"button\" style=\"\" id=\"media_dislike_69\" data-mediaid=\"69\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_69\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/hbs_GaWX5PI\" data-description=\"Haemochromatosis\" data-upvotes=\"0\" data-downvotes=\"1\" data-media=\"1242\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/hbs_GaWX5PI/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/hbs_GaWX5PI\" data-description=\"Haemochromatosis\" data-upvotes=\"0\" data-downvotes=\"1\" data-media=\"1242\">Haemochromatosis</a></td></tr><tr><td><span ><small>Armando Hasudungan - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2193\" data-mediaid=\"2193\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2193\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0</span><button type=\"button\" style=\"\" id=\"media_dislike_2193\" data-mediaid=\"2193\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2193\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr><tr><td>&nbsp;</td></tr><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/A7WwI2Hxy3A\" data-description=\"Understanding Haemochromatosis (Hereditary & Secondary)\" data-upvotes=\"0\" data-downvotes=\"1\" data-media=\"1562\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/A7WwI2Hxy3A/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/A7WwI2Hxy3A\" data-description=\"Understanding Haemochromatosis (Hereditary & Secondary)\" data-upvotes=\"0\" data-downvotes=\"1\" data-media=\"1562\">Understanding Haemochromatosis (Hereditary & Secondary)</a></td></tr><tr><td><span ><small>Rhesus Medicine - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2719\" data-mediaid=\"2719\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2719\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">0</span><button type=\"button\" style=\"\" id=\"media_dislike_2719\" data-mediaid=\"2719\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2719\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">1</span></td></tr></table>",
        "comment_count": 5,
        "concepts_for_notes": {
            "354": {
                "concept_text": "Haemochromatosis is autosomal recessive",
                "concept_percentile": "47"
            },
            "3415": {
                "concept_text": "Hemochromatosis is also known as 'bronze diabetes' due to iron-induced damage to the pancreas ",
                "concept_percentile": "50"
            },
            "4457": {
                "concept_text": "Early signs of haemochromatosis are fatigue, erectile dysfunction and arthralgia",
                "concept_percentile": "52"
            },
            "8427": {
                "concept_text": "Haemochromatosis - diabetes mellitus",
                "concept_percentile": "32"
            },
            "8428": {
                "concept_text": "Haemochromatosis - dilated cardiomyopathy",
                "concept_percentile": "32"
            },
            "8429": {
                "concept_text": "Haemochromatosis - arthritis",
                "concept_percentile": "37"
            }
        },
        "optimisation_reason": ""
    },
    {
        "question_id": "1_E_70",
        "new_question_id": "3610",
        "question_type": "1",
        "category": "7",
        "concept_id_link": "0",
        "notes_id_link": "1_1619",
        "theme": "Limping child",
        "instruction": "For each one of the following scenarios select the most likely diagnosis",
        "options": [
            "",
            "Perthes disease",
            "Septic arthritis/osteomyelitis",
            "Development dysplasia of the hip",
            "Trauma",
            "Slipped upper femoral epiphysis",
            "Transient synovitis",
            "Juvenile idiopathic arthritis",
            "",
            "",
            ""
        ],
        "num_of_options": 7,
        "questions": [
            "A 7-year-old with a one day history of a painful right hip. Just about able to walk but painful. Looks flushed and has a temperature of 38.7&#186;C",
            "Mz 8-yazft-axp otuxp ue zafqp fa tmhq m pueodqbmzok nqfiqqz ftq ewuz odqmeqe nqtuzp ftq dustf mzp xqrf tube",
            "Mz anqeq 13-kqmd-axp nak bdqeqzfe iuft m fia iqqw tuefadk ar dustf eupqp wzqq bmuz meeaoumfqp iuft m efurr dustf tub. Ftqdq ue za tuefadk ar fdmgym"
        ],
        "answers": [
            "2",
            "3",
            "5"
        ],
        "notes": [
            "The child is too unwell to make a diagnosis of transient synovitis",
            "",
            ""
        ],
        "exam_specific_explanation": "",
        "question": "A 7-year-old with a one day history of a painful right hip. Just about able to walk but painful. Looks flushed and has a temperature of 38.7&#186;C",
        "correct_answer": "2",
        "question_notes": "The child is too unwell to make a diagnosis of transient synovitis",
        "answer_order": "2",
        "answer": "2",
        "title": "Limping child",
        "body": "Causes of a limping child may vary according to age<br /><br /><div class=\"table-responsive\"><table class = \"tlarge table table-striped table-bordered\"  data-role=\"table\" id=\"tableid1\" ><thead><tr><th>Condition</th><th>Notes</th></tr></thead><tbody><tr><td><b>Transient synovitis</b></td><td>Acute onset<br />Usually accompanies viral infections, but the child is well or has a mild fever<br />More common in boys, aged 2-12 years</td></tr><tr><td><b>Septic arthritis/osteomyelitis</b></td><td>Unwell child, high fever</td></tr><tr><td><b>Juvenile idiopathic arthritis</b></td><td>Limp may be painless</td></tr><tr><td><b>Trauma</b></td><td>History is usually diagnostic</td></tr><tr><td><b>Development dysplasia of the hip</b></td><td>Usually detected in neonates<br />6 times more common in girls</td></tr><tr><td><b>Perthes disease</b></td><td>More common at 4-8 years<br />Due to avascular necrosis of the femoral head</td></tr><tr><td><b>Slipped upper femoral epiphysis</b></td><td>10-15 years  - Displacement of the femoral head epiphysis postero-inferiorly</td></tr></tbody></table></div>",
        "notes_hash": "ff1373b64db2e514ff90430e1f98fc6c",
        "knowledge_graph_node_id_link": 0,
        "concept": "",
        "concept_percentile": 0,
        "concept_colour": "",
        "number_attempts": "5082",
        "up_votes": "26",
        "down_votes": "39",
        "column_array": [
            0,
            "3924",
            "4461",
            "3660",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0",
            "0"
        ],
        "links": "",
        "media": "<table><tr><td colspan=\"2\"><a href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/uKmFTtCPdKM\" data-description=\"Paediatric Limp: Differential Frameworks\" data-upvotes=\"11\" data-downvotes=\"0\" data-media=\"1420\"><img border=\"0\" class=\"img-thumbnail\" alt=\"YouTube\" src=\"https://i1.ytimg.com/vi/uKmFTtCPdKM/mqdefault.jpg\" style=\"max-width:150px;\"></a></td></tr><tr ><td style=\"padding-top:10px\" colspan=\"2\"><a style=\"\" href=\"#\" class=\"media_link\" data-url=\"https://www.youtube.com/embed/uKmFTtCPdKM\" data-description=\"Paediatric Limp: Differential Frameworks\" data-upvotes=\"11\" data-downvotes=\"0\" data-media=\"1420\">Paediatric Limp: Differential Frameworks</a></td></tr><tr><td><span ><small>Townsend Teaching - YouTube</small></span></td><td style = \"float: right;width:115px;\"><button type=\"button\" style=\"\" id=\"media_like_2492\" data-mediaid=\"2492\" data-rating=\"1\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-up\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-up\"/></svg></button><span id=\"media_good_count_2492\" class = \"media_good_count\" style=\"color:green; font-size:85%;\">11</span><button type=\"button\" style=\"\" id=\"media_dislike_2492\" data-mediaid=\"2492\" data-rating=\"0\" class=\"rate-media btn btn-link\"><svg class=\"bi bi-hand-thumbs-down\" width=\"16\" height=\"16\"><use xlink:href=\"#icon-hand-thumbs-down\"/></svg></button><span id=\"media_bad_count_2492\" class = \"media_bad_count\" style=\"color:red; font-size:85%;\">0</span></td></tr></table>",
        "comment_count": 6,
        "concepts_for_notes": [],
        "optimisation_reason": ""
    }
]